LON:CLIN - Clinigen Group Share Price, Forecast & News

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

Clinigen Group announced a dividend on Thursday, September 19th. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 4.75 per share on Friday, November 29th. This represents a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is an increase from Clinigen Group's previous dividend of $1.95. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.

Clinigen Group PLC (LON:CLIN) issued its earnings results on Tuesday, February, 27th. The company reported $21.20 EPS for the quarter, beating the Zacks' consensus estimate of $20.30 by $0.90. The company had revenue of $167.80 million for the quarter. View Clinigen Group's Earnings History.

Clinigen Group is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Clinigen Group.

5 Wall Street analysts have issued 1 year price targets for Clinigen Group's stock. Their forecasts range from GBX 1,035 to GBX 1,640. On average, they anticipate Clinigen Group's stock price to reach GBX 1,302 in the next year. This suggests a possible upside of 48.8% from the stock's current price. View Analyst Price Targets for Clinigen Group.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

Press coverage about CLIN stock has been trending positive this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Clinigen Group earned a news impact score of 2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Clinigen Group.

Some companies that are related to Clinigen Group include SmileDirectClub (SDC), China Biologic Products (CBPO), bluebird bio (BLUE), ICU Medical (ICUI), Global Blood Therapeutics (GBT), Spark Therapeutics (ONCE), Envista (NVST), Nevro (NVRO), BridgeBio Pharma (BBIO), Healthscope (HSO), ConvaTec Group (CTEC), ELEKTA AB/ADR (EKTAY), Evotec (EVTCY), Adaptive Biotechnologies (ADPT) and Nektar Therapeutics (NKTR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CLIN stock can currently be purchased for approximately GBX 875.

Clinigen Group has a market capitalization of £1.16 billion and generates £456.90 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

The official website for Clinigen Group is http://www.clinigengroup.com/.

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.